Market News & Trends
EMD Millipore Announces Partnership With NIH Consortium
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced it has entered into an agreement with an academic consortium funded…
Foster Reports Increased Interest in Implantable Applications
Foster Corporation, a leader in custom medical polymers, recently reported increased interest in implantable medical device applications by polymer suppliers. While risk mitigation remains a…
Theravance & Merck Sign Major Cardiovascular Collaboration
Theravance, Inc.recently announced it has signed a collaboration agreement with Merck, known as MSD outside the United States and Canada, to discover, develop, and commercialize…
10/16/2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed…
Aptalis Sponsors AAPS Research Achievement Awards
Aptalis Pharmaceutical Technologies, formerly Eurand, focused on developing differentiated oral products utilizing its pharmaceutical technologies, recently announced its sponsorship of the American Association of Pharmaceutical…
Bend Research Receives US Patents for Technology to Enhance Bioavailability
Bend Research Inc. recently announced it has received two new US patents related to its pioneering efforts to improve the oral bioavailability of low-solubility drugs.…
Catalent Licenses Innovative Technology
Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed by the New…
Frost & Sullivan Predicts Growth for Therapeutic Monoclonal Antibodies
Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclonal antibodies-based therapeutics against conventional chemical drugs. However, high developmental costs…
Future of Pharmaceutical R&D Requires Innovative Dosage Formulations
A survey of 500 pharmaceutical industry influencers reveals that four out of five surveyed (82%) believe innovative dosage form technologies are required to meet the…
Pharmacyclics Inks Agreement With Novo Nordisk
Pharmacyclics Inc. recently announced it has signed an agreement with Novo Nordisk A/S giving the Danish insulin producer rights to certain uses of its Factor…
10/10/2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company and Bioprocess Capital Ventures, recently…
4P Therapeutics Announces Major Development Partnership
4P Therapeutics, a drug delivery company with expertise in novel drug delivery technologies, recently announced a partnership with Medicure Inc. for the development of a…
Bend Research & Dow Chemical to Develop Drug-Solubility Solutions & New Polymers
Bend Research Inc. and The Dow Chemical Company have formed an exclusive collaboration to provide science-based spray-dried dispersion (SDD) solutions and select enabling new polymers…
Catalent Strikes Agreement With Vivus
Catalent Pharma Solutions recently announced it has entered into a Supply Agreement with VIVUS, Inc. to supply Qsymia capsules, a proprietary combination phentermine and extended-release…
Cleveland BioLabs & Incuron Announce Orphan Drug Status
Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company and Bioprocess Capital Ventures, recently announced that curaxin CBL0102 (quinacrine) has been granted…
Mayne Pharma Announces Major Acquisition
Mayne Pharma Group Limited recently announce it has entered into a binding agreement to acquire Metrics, Inc. Consideration for the acquisition will comprise an up-front…
Patheon Launches Innovative Meet the Experts Program
Patheon Inc. recently announced the launch of its new Meet the Experts program. The program provides direct access to scientific and technical experts, both from…
Actinium Announces Multi-Million Financing
Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a new round of fundraising that will culminate in a…
Clinipace Worldwide Buys Paragon Biomedical; Plans New Hires
Clinipace Worldwide and Paragon Biomedical, Inc. recently announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of the privately held,…
Covidien's Mallinckrodt to Acquire Company for $100 Million
Mallinckrodt, the Pharmaceuticals business of Covidien, recently announced a definitive agreement to acquire CNS Therapeutics, Inc. Mallinckrodt will acquire all of the outstanding capital stock…
